Literature DB >> 3352917

Rare Ha-ras and c-mos alleles in patients with intracranial tumors.

U Diedrich1, O Eckermann, J Schmidtke.   

Abstract

The occurrence of rare hypervariable Ha-ras alleles or of a rare c-mos allele in white blood cell DNA is claimed to be associated with susceptibility to cancer. We analyzed a group of patients with intracranial tumors to determine whether the occurrence of rare alleles at the Ha-ras locus and at the c-mos locus was increased in comparison with normal individuals. We found a higher incidence of rare hypervariable Ha-ras alleles (9.5% to 3%) and a 5 kilobase EcoRI c-mos allele (2.5% to 0%) in the patients. These results are consistent with the opinion that such unusual alleles are associated with a predisposition to intracranial tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3352917     DOI: 10.1212/wnl.38.4.587

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.

Authors:  R Klingel; P Mittelstaedt; W G Dippold; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

2.  Population genetics of the HRAS1 minisatellite locus.

Authors:  B Devlin; T Krontiris; N Risch
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

3.  Inhibition of collagenolytic activity relates to quantitative reduction of invasion in vitro in a c-Ha-ras transfected glial cell line.

Authors:  E R Boghaert; S K Chan; C Zimmer; D Grobelny; R E Galardy; T C Vanaman; S G Zimmer
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.

Authors:  R Dolcetti; S Pelucchi; R Maestro; S Rizzo; A Pastore; M Boiocchi
Journal:  Eur Arch Otorhinolaryngol       Date:  1991       Impact factor: 2.503

5.  Ha-ras rare alleles in breast cancer susceptibility.

Authors:  K Conway; S Edmiston; D B Fried; B S Hulka; P A Garrett; E T Liu
Journal:  Breast Cancer Res Treat       Date:  1995-07       Impact factor: 4.872

Review 6.  The biology of meningiomas.

Authors:  I E McCutcheon
Journal:  J Neurooncol       Date:  1996-09       Impact factor: 4.130

7.  Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue.

Authors:  U Diedrich; S Soja; J Behnke; B Zoll
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

8.  Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis.

Authors:  U Diedrich; J Lucius; E Baron; J Behnke; B Pabst; B Zoll
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

9.  Amplification and expression of the epidermal growth factor receptor gene during the progression of neuroepithelial tumours in vivo.

Authors:  U Diedrich; E Baron; J Behnke; B Zoll
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.